Biomarin Pharmaceutical Inc at Piper Sandler Healthcare Conference (Virtual) Transcript
Okay. Great. Well, let's go ahead and get started with our next session. Thanks, everybody, for dialing in. My name is Chris Raymond. I'm one of Piper Sandler's biotech analysts. And very pleased to have with us our next presenter and company for our fireside chat format here, BioMarin. We're lucky to have with us the full complement of the management team here. We have CEO and Chairman, J.J. Bienaimé; President of Worldwide R&D, Hank Fuchs; and Brian Mueller, who is the CFO.
So as is the format that we've done in the past, we'll be -- this will be a fireside chat format. But just to maybe level set the story for investors, maybe for the few who might not necessarily know the story. J.J., if you wouldn't mind giving us a 2- to 3-minute or so intro on BioMarin, that would be great, and then we'll dive into the Q&A.
Yes. Thank you, Chris. Thank you for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
